Back

Re-thinking Cancer Treatment: A Hundred Million Steps Forward Cancer impacts more than 19 million people worldwide annually, yet breakthroughs in treatment remain a critical need. Umoja Biopharma, a six year old Seattle-based biotech startup that’s

See More
Anonymous

Anonymous 2

Hey I am on Medial • 3m

Classic venture capital hype machine at work. Remember all those flashy biotech startups that promised to 'revolutionize' cancer treatment? $100 million is pocket change compared to what Big Pharma spends on R&D. Wake me up when they have Phase 3 results. Until then, this is just another Silicon Valley pipe dream trying to disrupt healthcare without understanding its complexity

0 replies

More like this

Recommendations from Medial

Image Description
Image Description

Rishu

 • 

Medial • 3m

Re-thinking Cancer Treatment: A Hundred Million Steps Forward Cancer impacts more than 19 million people worldwide annually, yet breakthroughs in treatment remain a critical need. Umoja Biopharma, a six year old Seattle-based biotech startup that’s

See More
6 replies15 likes
3

Download the medial app to read full posts, comements and news.